SUBTYPE SELECTIVE LIGANDS FOR OPIATE RECEPTORS
SUBTYPE SELECTIVE LIGANDS FOR OPIATE RECEPTORS
批准号:
2598853
负责人:
SUBRAMANIAM ANANTHAN
金额:
$4.15万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-04-01 至 2000-03-31
中文摘要
各种各样的生理和药理作用都是由
通过中枢神经系统的阿片受体。在三个人中
阿片受体(Mu、Delta、Kappa)的成熟类型
研究工作将注意力集中在受体的Delta亚型上。
大量证据表明,德尔塔受体参与了
在调节脊髓和脊柱上的抗伤害感受中,胃肠道
在调节容忍和依赖的发展过程中
阿片类药物和其他滥用药物,如可卡因。一个重要的
阿片受体药理学的最新进展
三角洲受体亚型的生物化学和药理学研究
它们被称为Delta/1和Delta/2亚型或Delta/NCX
和Delta/Cx受体。最近的研究表明,异质性存在。
在这些亚型的Delta受体中,进一步的研究可能最终
导致它们被归类为其他亚型。身份识别
阿片受体亚型的研究是一项令人兴奋的新进展,
为亚型选择性药物的开发提供机遇
作为新型止痛剂的治疗应用(不含胃肠道,
呼吸道和药物依赖副作用)和作为治疗药物
与药品添加有关的问题。
高选择性激动剂和拮抗剂配体的研究进展
对于各种亚型的阿片受体来说都是原发的
重要的是因为稳定和选择性的配体是用作
作为药理工具和副作用最小的选择性药物。
拟议工作的一个长期目标是发展稳定
具有特定激动剂或拮抗剂活性且高活性的非肽配体
这些不同的Delta受体亚型的选择性。为了努力
实现这些目标,在此提出的是一项合作努力,包括
体外药物设计、合成及体内外评价
在组织和动物模型中。这是一种在
新型配体的设计是利用最近观察到的Delta
以某些吗啡类化合物为起点的选择性
合理的结构操作,可能会带来预期的效果和
Delta型受体亚型的选择性。综合与评价
所设想的吲哚、吡啶和嘧啶吗啉类目标化合物
应提供有关配体结合特性的新见解
阿片受体亚型。此外,拟议的研究
应有助于识别新的选择性Delta受体亚型
可能用作止痛药和治疗药物的潜在药物
治疗耐受性和依赖性相关问题的药物
滥用药物。
英文摘要
A wide variety of physiological and pharmacological actions are mediated
by the opiate receptors of the central nervous system. Among the three
well established classes of opiate receptors (mu, delta, kappa) recent
research efforts have focused attention on the delta subtype of receptors.
A large body of evidence indicates that the delta receptors are involved
in mediating spinal and supraspinal antinociception, gastrointestinal
transit and in modulating the development of tolerance and dependence to
opioid and other drugs of abuse such as cocaine. A significant
development in the opioid delta receptor pharmacology is the recent
biochemical and pharmacological delineation of subtypes of delta receptors
which have been termed the delta/1 and delta/2 subtypes or the delta/ncx
and delta/cx receptors. Recent studies suggest that heterogeneity exists
among these subtypes of delta receptors and further studies may eventually
lead to their classification into additional subtypes. The identification
of subtypes of opioid delta receptors is an exciting new development which
provides opportunities for development of subtype selective drugs for
therapeutic applications as novel analgesics (devoid of gastrointestinal,
respiratory and drug dependence side effects) and as treatment drugs for
problems related to drug additions.
The development of agonist and antagonist ligands with high selectivity
for the various subtypes of opioid delta receptors is of primary
importance since stable and selective ligands are needed for use as
pharmacological tools and as selective drugs with minimal side effects.
A long term objective of the proposed work is the development of stable
nonpeptide ligands with specific agonist or antagonist activity and high
selectivity for these various delta receptor subtypes. In an effort to
achieve these goals, proposed herein is a collaborative effort involving
drug design, synthesis and in vitro and in vivo evaluations in isolated
tissues and in animal models. An approach that has been adopted in the
design of novel ligands is to utilize the recent observations of delta
selectivity for some of the morphinan derivatives as a starting point for
rational structural manipulations that might impart desired efficacy and
selectivity for the delta receptor subtypes. The synthesis and evaluation
of the envisioned indolo-, pyrido- and pyrimidomorphinan target compounds
should provide new insights regarding the ligand binding characteristics
of the opioid delta receptor subtypes. Moreover, the proposed studies
should aid in the identification of new delta receptor subtype selective
agents that may potentially be useful as analgesics and as therapeutic
agents for the treatment of tolerance and dependence problems associated
with drugs of abuse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In Vitro Assessments Program Central Data Management Center
-
批准号:9360455
-
项目类别:
-
资助金额:$12.56万
-
财政年份:2016
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain
-
批准号:9113533
-
项目类别:
-
资助金额:$87.99万
-
财政年份:2015
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain
-
批准号:8961201
-
项目类别:
-
资助金额:$91.26万
-
财政年份:2015
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain
-
批准号:9303324
-
项目类别:
-
资助金额:$88.22万
-
财政年份:2015
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Task Order E05: In Vitro Testing Central Data Management Center
-
批准号:9148155
-
项目类别:
-
资助金额:$31.59万
-
财政年份:2015
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Task E04: Central Data Management Center
-
批准号:8936425
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2014
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
In Vitro Assessments for Antimicrobial Activity
-
批准号:8341820
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2011
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Targeted Library Synthesis and Screening: Allosteric Modulators of Transporters
-
批准号:8698720
-
项目类别:
-
资助金额:$38.87万
-
财政年份:2010
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Targeted Library Synthesis and Screening: Allosteric Modulators of Transporters
-
批准号:8510615
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2010
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Targeted Library Synthesis and Screening: Allosteric Modulators of Transporters
-
批准号:7998796
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2010
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Targeted Library Synthesis and Screening: Allosteric Modulators of Transporters
-
批准号:8486032
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2010
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Targeted Library Synthesis and Screening: Allosteric Modulators of Transporters
-
批准号:8116614
-
项目类别:
-
资助金额:$37.44万
-
财政年份:2010
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Development of Dopamine D3 Ligands as Medications for Psychostimulant Addiction
-
批准号:7784925
-
项目类别:
-
资助金额:$47.82万
-
财政年份:2009
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Development of Dopamine D3 Ligands as Medications for Psychostimulant Addiction
-
批准号:7934699
-
项目类别:
-
资助金额:$47.63万
-
财政年份:2009
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
Development of Dopamine D3 Ligands as Medications for Psychostimulant Addiction
-
批准号:8134448
-
项目类别:
-
资助金额:$46.41万
-
财政年份:2009
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
MEDICINAL CHEMISTRY SYNTHESIS OF POTENTIAL TREATMENT
-
批准号:6070655
-
项目类别:
-
资助金额:$17.87万
-
财政年份:1997
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
MEDICINAL CHEMISTRY SYNTHESIS OF POTENTIAL TREATMENT
-
批准号:2834317
-
项目类别:
-
资助金额:$17.87万
-
财政年份:1997
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
MEDICINAL CHEMISTRY SYNTHESIS OF POTENTIAL TREATMENT
-
批准号:2662861
-
项目类别:
-
资助金额:$17.87万
-
财政年份:1997
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
SUBTYPE SELECTIVE LIGANDS FOR OPIATE RECEPTORS
-
批准号:2121695
-
项目类别:
-
资助金额:$19.9万
-
财政年份:1995
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
NOVEL NONPEPTIDE LIGANDS FOR THE OPIOID RECEPTORS
-
批准号:6494309
-
项目类别:
-
资助金额:$6.9万
-
财政年份:1995
-
负责人:SUBRAMANIAM ANANTHAN
-
依托单位:
海外基金